MedPath

Glycemic Response in Persons With Type 2 Diabetes Mellitus

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Registration Number
NCT04168541
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

This will be a randomized crossover design. The subjects will be randomized to one of six interventions on six separate study days, one week apart.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Area under the blood glucose curve (ACU 0-240 minutes)Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
Secondary Outcome Measures
NameTimeMethod
Insulinogenic index [Change in Ins30/Change in Glu30][Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes]
Area under the insulin curves (AUC 0-240)Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes

Trial Locations

Locations (1)

Orange County Research Center

🇺🇸

Tustin, California, United States

Orange County Research Center
🇺🇸Tustin, California, United States
© Copyright 2025. All Rights Reserved by MedPath